Clinical Trials · NCT00003645

Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

TerminatedPhase 3Gonadorelin (Prohibited)
Phase
Phase 3
Recruitment status
Terminated
Sponsor
M.D. Anderson Cancer Center
Enrollment
64
Start date
Jun 1999
Locations
1 site, United States
Primary endpoint
Number of Participants With Disease Free Survival at 5 Years
View Gonadorelin compound reference